Improved depression‐like behaviors in mice; reduced activation of astrocytes and microglia, and decreased neuroinflammation; increased BDNF expression and enhanced neurogenesis; restored ATP production in the hippocampus and reduced oxidative stress. This evidence concerns the gene BDNF and major depressive disorder.